Divis Laboratories Financial Statements

Divis Laboratories (DIVISLAB) reported revenue of ₹105.60B in FY2026 with net income of ₹25.68B. Total assets stood at ₹200.33B. Net worth was ₹167.61B (₹16,761 Cr) and free cash flow was ₹2.18B.

Divis Laboratories Income Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Revenue		93.60B	105.60B
Cost of Rev. Cost of Revenue		-37.25B	-40.93B
Gross Profit		56.35B	64.67B
SGA Sales, General & Admin		-26.67B	-30.26B
Op. Income Operating Income		25.66B	29.78B
PBT Profit Before Tax		29.16B	33.88B
Net Income		21.91B	25.68B
Dil. Shares Diluted Shares		265.48M	265.43M
Diluted EPS		82.53	96.75

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Divis Laboratories's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Divis Laboratories Balance Sheet

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Curr. assets Total current assets		100.81B	110.96B
Non-curr. assets Total non-current assets		68.51B	89.37B
Total assets		169.32B	200.33B
Curr. liabilities Total current liabilities		14.52B	20.43B
Non-curr. liab. Total non-current liabilities		5.11B	12.29B
Total liabilities		19.63B	32.72B
Total equity		149.69B	167.61B
Total liab. & eq. Total liabilities & equity		169.32B	200.33B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Divis Laboratories's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Divis Laboratories Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2025 – FY 2026

Item	Chart	2025	2026
Net Income		29.16B	33.88B
Operating CF Cash flow Operating Activities		16.53B	27.38B
Capex Investments in PPE		-14.38B	-25.20B
Investing CF Cash flow Investing Activities		-8.04B	-22.19B
Dividend Paid		-7.96B	-7.97B
Financing CF Cash flow Financing Activities		-7.99B	-8.04B
Cash (start) Cash at beginning of period		3.63B	4.13B
Cash (end) Cash at end of period		4.13B	1.28B
FCF Free Cash Flow		2.15B	2.18B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Divis Laboratories's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2026